financetom
Business
financetom
/
Business
/
Ginkgo Bioworks, Bayer Extend Biological Crop Research Partnership
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ginkgo Bioworks, Bayer Extend Biological Crop Research Partnership
Oct 31, 2025 5:59 AM

08:43 AM EDT, 10/31/2025 (MT Newswires) -- Ginkgo Bioworks ( DNA ) said it extended its multiyear partnership with Bayer to develop biological products for agriculture by adding microbial nitrogen fixation.

Under the renewed agreement, Bayer will keep the rights to commercialize resulting biological products as supplements to synthetic fertilizers, the company said.

Ginkgo said Bayer remains a partner in its agricultural biologicals platform, which focuses on biological crop protection, nitrogen fixation, and carbon sequestration.

Shares of the company were up 2.7% in recent Friday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sonida Senior Living Completes $1.8 Billion Strategic Merger with CNL Healthcare Properties, Inc.
Sonida Senior Living Completes $1.8 Billion Strategic Merger with CNL Healthcare Properties, Inc.
Mar 11, 2026
Creates $3.3 Billion Pure-Play Senior Housing Owner-Operator and Eighth Largest Owner of U.S. Senior Living Assets1 Estimated Normalized FFO Per Share Accretion of 62% on a Run-Rate Basis with Substantial Near-Term and Future Synergies Strengthens Balance Sheet Through Immediate Deleveraging and Significantly Deepened Access to Capital DALLAS--(BUSINESS WIRE)-- Sonida Senior Living, Inc. ( SNDA ) (“Sonida” or the “Company”)...
Hims & Hers Announces Agreement to Acquire Eucalyptus, Accelerating Its Vision to Become the Leading Global Consumer Health Platform
Hims & Hers Announces Agreement to Acquire Eucalyptus, Accelerating Its Vision to Become the Leading Global Consumer Health Platform
Mar 11, 2026
Eucalyptus is a consumer healthcare leader in Australia, the UK and Germany, with expanding new operations in Japan and Canada. SAN FRANCISCO--(BUSINESS WIRE)-- Hims & Hers Health, Inc. ( HIMS ) , the leading health and wellness platform, today announced it has entered into a definitive agreement to acquire Eucalyptus, an international leader in digital health, accelerating the company’s...
Janus Henderson Group plc Board of Directors Determines by Unanimous Vote that Victory Capital’s Proposal Is Not Superior and Reaffirms Recommendation of Transaction with Trian and General Catalyst
Janus Henderson Group plc Board of Directors Determines by Unanimous Vote that Victory Capital’s Proposal Is Not Superior and Reaffirms Recommendation of Transaction with Trian and General Catalyst
Mar 11, 2026
Special Committee of Board and Its Advisors Reviewed Victory’s Non-Binding Unsolicited Proposal and Determines It Is Not in Best Interests of Janus Henderson ( JHG ) and Its Shareholders Reaffirms Recommendation of Take-Private by Trian and General Catalyst Victory’s Proposal Not Actionable; Presents Significant Closing Risk and Uncertain Value LONDON--(BUSINESS WIRE)-- Janus Henderson Group plc ( JHG ) today...
Organigram Announces C$65.2 Million BAT Private Placement Investment in Connection with the Acquisition of Sanity Group
Organigram Announces C$65.2 Million BAT Private Placement Investment in Connection with the Acquisition of Sanity Group
Mar 11, 2026
Organigram shares priced at average C$2.72 per share representing a combination of Top-Up Rights being exercised at C$2.34/share and shares issued in connection with Sanity acquisition priced at C$3.00/share. TORONTO--(BUSINESS WIRE)-- Organigram Global Inc. ( OGI ) , (the “Company” or “Organigram”), a leading global cannabis company, today announced that it has entered into a subscription agreement (the “Subscription...
Copyright 2023-2026 - www.financetom.com All Rights Reserved